STAT+: Covid-19 burnished pharma’s reputation among patient groups, but access to medicines is now an issue

In the wake of the Covid-19 pandemic, the pharmaceutical industry enjoyed something of an afterglow, as far as patient advocacy groups were concerned.

Not anymore.

Continue to STAT+ to read the full story…

Read Original Article: STAT+: Covid-19 burnished pharma’s reputation among patient groups, but access to medicines is now an issue »